RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

08:00 EDT 21st May 2018 | BioPortfolio

Summary of "RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape."

No Summary Available


Journal Details

This article was published in the following journal.

Name: Nucleic acid therapeutics
ISSN: 2159-3345


DeepDyve research library

PubMed Articles [8503 Associated PubMed Articles listed on BioPortfolio]

Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs.

RNA interference (RNAi) is a fundamental cellular process for the posttranscriptional regulation of gene expression. RNAi can exogenously be modulated by small RNA oligonucleotides, such as microRNAs ...

Endosomal Size and Membrane Leakiness Influence Proton Sponge-Based Rupture of Endosomal Vesicles.

In gene therapy, endosomal escape represents a major bottleneck since nanoparticles often remain entrapped inside endosomes and are trafficked towards the lysosomes for degradation. A detailed underst...

The proton sponge hypothesis: Fable or Fact?

In non-viral gene therapy, cationic polymers and lipids are frequently used to encapsulate macromolecular therapeutics into nanoparticles. During their journey to deliver the cargo to the intended int...

Viral escape from endosomes and host detection at a glance.

In order to replicate, most pathogens need to enter their target cells. Many viruses enter the host cell through an endocytic pathway and hijack endosomes for their journey towards sites of replicatio...

GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.

Short-interfering RNA (siRNA)-induced RNAi responses have great potential to treat a wide variety of human diseases from cancer to pandemic viral outbreaks to Parkinson's Disease. However, before siRN...

Clinical Trials [2783 Associated Clinical Trials listed on BioPortfolio]

ESCAPE Mechanistic Substudies - Ancillary to ESCAPE

To determine the value of serum markers as surrogate endpoints and hemodynamic biomarkers of congestive heart failure.

Randomized Controlled Trial of Social Network Targeting in Honduras

Social network targeting strategies can be used to improve the delivery and uptake of health interventions. We will enroll approximately 30,000 individuals into a randomized controlled tri...

Association Between Holter Electro Hysterogram (EHG) and Risk of Preterm Delivery in Women Hospitalized for Threatened Premature Delivery

Preterm delivery accounts for about 10% of deliveries in France. Prematurity is the leading cause of perinatal morbidity and mortality in economically developed countries. Despite the deve...

ESCAPE-pain Programme in Malaysia

The overall aim of this study is to develop an evidence based exercise programme for the management of knee osteoarthritis which is feasible and acceptable to patients and healthcare profe...

Study to Explore the Mechanism of Acquired Immune Escape In Participants With Metastatic Cancer Progressing on CPI Therapy

The purpose of this study is to identify mechanisms associated with acquired immune escape by comparing baseline and at-progression tissue samples from participants who derive clinical ben...

Medical and Biotech [MESH] Definitions

Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity.

Nanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging.

Provision of physical and biological barriers to the dissemination of potentially hazardous biologically active agents (bacteria, viruses, recombinant DNA, etc.). Physical containment involves the use of special equipment, facilities, and procedures to prevent the escape of the agent. Biological containment includes use of immune personnel and the selection of agents and hosts that will minimize the risk should the agent escape the containment facility.

The care of a fetus or newborn given before, during, and after delivery from the 28th week of gestation through the 7th day after delivery.

Delivery of the FETUS and PLACENTA under the care of an obstetrician or a health worker. Obstetric deliveries may involve physical, psychological, medical, or surgical interventions.

Quick Search


DeepDyve research library

Searches Linking to this Article